[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368333-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368333-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-status-of-sox2-expression-in-gastric-cancers-with-induction-of-cdx2-defines-groups-with-different-genomic-landscapes","The Status of SOX2 Expression in Gastric Cancers with Induction of CDX2 Defines Groups with Different Genomic Landscapes","","Gastric adenocarcinoma remains highly lethal, particularly in metastatic disease where limited treatments enable only palliation. This study examines stem cell transcription factors SOX2 and CDX2 in gastric cancer pathogenesis using TCGA gastric adenocarcinoma cohorts. Cases were divided by CDX2 induction with either SOX2 suppression versus sustained SOX2 expression, based on an mRNA z-score threshold. Clinical-pathologic features and genomic alterations were then compared between groups, revealing distinct tumor mutation and instability patterns associated with SOX2 suppression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-status-of-sox2-expression-in-gastric-cancers-with-induction-of-cdx2-defines-groups-with-different-genomic-landscapes/368333/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-status-of-sox2-expression-in-gastric-cancers-with-induction-of-cdx2-defines-groups-with-different-genomic-landscapes/368333.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were the two gastric cancer groups defined in this study?","Question",{"text":63,"@type":64},"The TCGA gastric adenocarcinoma cohort was used, retaining two groups with CDX2 induction. One group had SOX2 suppression and the other had sustained SOX2 expression based on SOX2 mRNA expression z-scores relative to normal samples.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What genomic differences were observed between the SOX2-suppressed and SOX2-maintained groups?",{"text":68,"@type":64},"The SOX2-suppressed group showed higher prevalence of MSI-high cancers and higher tumor mutation burden, along with increased mutation rates in several gastric cancer-associated genes, including ARID1A and KMT2 family genes, and receptor tyrosine kinase genes ERBB4 and FGFR1.",{"name":70,"@type":61,"acceptedAnswer":71},"Were SOX2 expression levels found to be prognostic?",{"text":72,"@type":64},"No. Despite notable differences in the genomic landscape depending on SOX2 mRNA expression level, SOX2 mRNA expression levels were not prognostic.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368333,1790577712,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nThe Status of SOX2 Expression in Gastric Cancers with Induction of CDX2 Defines Groups with Different Genomic Landscapes  \nIoannis A. Voutsadakis 1,2  \nAcademic Editor: David Gómez Matallanas  \nReceived: 10 February 2025  \nRevised: 23 February 2025  \nAccepted: 24 February 2025  \nPublished: 26 February 2025  \nCitation: Voutsadakis, I.A. The Status of SOX2 Expression in Gastric Cancers with Induction ofCDX2 Defines Groups with Different Genomic Landscapes. Genes 2025, 16, 279 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)genes16030279  \nCopyright: © 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Algoma District Cancer Program, Sault Area Hospital, 750 Great Northern Road, Sault Ste. Marie, ON P6B 0A8, Canada; ivoutsadakis@yahoo.com or [ivoutsadakis@nosm.ca](ivoutsadakis@nosm.ca)  \n2 Section of Internal Medicine, Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada  \nAbstract: Background: Gastric adenocarcinoma is a highly lethal neoplasm with a short survival especially when metastatic. Few effective treatments are available for the control of the disease and palliation of patients with metastatic gastric cancer. Although progress has been made in the elucidation of molecular pathways invoked in gastric carcinogenesis, this knowledge has not yet led to major breakthroughs, in contrast to several other types of cancer. The role of stem cell transcription factors SOX2 and CDX2 is of particular interest in the pathogenesis of gastric cancer. Methods: The cohort of gastric adenocarcinomas from The Cancer Genome Atlas (TCGA) was interrogated and two groups of gastric cancers, with CDX2 induction and SOX2 suppression on the one hand and with CDX2 induction and SOX2 maintained expression on the other hand were retained. The induction of expression of the two transcription factors was defined as a mRNA expression z score compared with normal samples above zero. The two groups were compared for clinical-pathologic and genomic differences. Results: Among gastric cancers with up-regulated CDX2 mRNA, cancers with suppressed SOX2 mRNA were slightly more numerous (55.9%) than those with a maintained SOX2 expression. The SOX2 suppressed group had a higher prevalence of MSI high cancers (30.9% versus 10%) and of cases with high tumor mutation burden (35% versus 12.4%) than cancers with a SOX2 maintained expression, which presented more frequently high Chromosomal Instability (CIN) . The group with SOX2 suppression had higher rates of mutations in many gastric cancer-associated genes such as epigenetic modifiers ARID1A, KMT2D, KMT2C, and KMT2B, as well as higher rates of mutations in genes encoding for receptor tyrosine kinases ERBB4 and FGFR1 . On the other hand, TP53 mutations and amplifications in MYC, ERBB2, and CCNE1 were more common in the group with a maintained expression of SOX2, approaching significance for MYC. Conclusions: Notable differences are present in the genomic landscape of CDX2-induced gastric cancer depending on the level of expression of SOX2 mRNA. Despite this, SOX2 mRNA expression levels were not prognostic.  \nKeywords: gastric adenocarcinoma; intestinal metaplasia; intestinal type; transcription factors; SOX2  \n1. Introduction  \nGastric adenocarcinomas are prevalent cancers of the gastrointestinal tract and are among the top causes of cancer mortality across populations [1]. Globally over 950,000 new cases and 650,000 deaths related to gastric cancer are recorded annually, making the disease the fifth most prevalent and fifth most lethal cancer [1] . Despite advances in treatment,  \nmetastatic disease is almost invariably lethal. Most patients with metastat","cbCaikC28edPUXTS","https://ap.wps.com/l/cbCaikC28edPUXTS","pdf",3253531,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Global burden and treatment context\n## Histologic subtypes and genomic differences","[{\"question\":\"How were the two gastric cancer groups defined in this study?\",\"answer\":\"The TCGA gastric adenocarcinoma cohort was used, retaining two groups with CDX2 induction. One group had SOX2 suppression and the other had sustained SOX2 expression based on SOX2 mRNA expression z-scores relative to normal samples.\"},{\"question\":\"What genomic differences were observed between the SOX2-suppressed and SOX2-maintained groups?\",\"answer\":\"The SOX2-suppressed group showed higher prevalence of MSI-high cancers and higher tumor mutation burden, along with increased mutation rates in several gastric cancer-associated genes, including ARID1A and KMT2 family genes, and receptor tyrosine kinase genes ERBB4 and FGFR1.\"},{\"question\":\"Were SOX2 expression levels found to be prognostic?\",\"answer\":\"No. Despite notable differences in the genomic landscape depending on SOX2 mRNA expression level, SOX2 mRNA expression levels were not prognostic.\"}]","The Status of SOX2 Expression in Gastric Cancers with Induction of CDX2 Defines Groups with Different Genomic Landscapes | PDF",1790176353,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccb904f0d8d1003f77c3ddcbe75cfff8.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/394088eb767fc388245783736bdce8e1.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05c9402aa54e321c6f4b8d9c7f15c4e6.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bc22df2e16de7a997f810c908b38389.webp",980,1385]